[¹⁸F]FDG

Clinical Evaluation	Glucose metabolism
Type of Imaging	PET
Grade of Recommendation	A (strongly recommended)
Level of Evidence	well-established clinical and Nuclear Medicine recommendations
Effective Dose	19.0 µSv/MBq
Bibliographic Reference	Fizazi K, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; ht... read more Fizazi K, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; https://doi.org/10.1093/annonc/mdv305 Losa F, et al. SEOM clinical guideline on unknown primary cancer (2017). Clin Transl Oncol. 2018; https://doi.org/10.1007/s12094-017-1807-y read less

Clinical Evaluation
Glucose metabolism
Type of Imaging
PET
Grade of Recommendation
A (strongly recommended)
Level of Evidence
well-established clinical and Nuclear Medicine recommendations
Effective Dose
19.0 µSv/MBq
Bibliographic Reference
Fizazi K, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; ht... read more Fizazi K, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015; https://doi.org/10.1093/annonc/mdv305 Losa F, et al. SEOM clinical guideline on unknown primary cancer (2017). Clin Transl Oncol. 2018; https://doi.org/10.1007/s12094-017-1807-y read less

[18F]FDG